Functional connectomic profile correlates with effective anterior thalamic stimulation for refractory epilepsy
Brain Stimulation · 2023-09 · 16 (5) · 1302-1309
DOI: 10.1016/j.brs.2023.08.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Stimulation, 2023-09. Verfasst von Cuiping Xu und 17 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Neurological Disorders, Beijing, China; Department of Functional Neurosurgery, Beijing Institute of Functional Neurosurgery, Xuan…. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Connectome, Deep Brain Stimulation, Anterior Thalamic Nuclei. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park, National Key Research and Development Program of China.
Abstract (Originalsprache)
BACKGROUND: Deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) is an effective treatment for refractory epilepsy; however, seizure outcome varies among individuals. Identifying a reliable noninvasive biomarker to predict good responders would be helpful. OBJECTIVES: To test whether the functional connectivity between the ANT-DBS sites and the seizure foci correlates with effective seizure control in refractory epilepsy. METHODS: We performed a proof-of-concept pilot study of patients with focal refractory epilepsy receiving ANT-DBS. Using normative human connectome data derived from 1000 healthy participants, we investigated whether intrinsic functional connectivity between the seizure foci and the DBS site was associated with seizure outcome. We repeated this analysis controlling for the extent of seizure foci, distance between the seizure foci and DBS site, and using functional connectivity of the ANT instead of the DBS site to test the contribution of variance in DBS sites. RESULTS: Eighteen patients with two or more seizure foci were included. Greater functional connectivity between the seizure foci and the DBS site correlated with more favorable outcome. The degree of functional connectivity accounted for significant variance in clinical outcomes (DBS site: |r| = 0.773, p < 0.001 vs ANT-atlas: |r| = 0.715, p = 0.001), which remained significant when controlling for the extent of the seizure foci (|r| = 0.773, p < 0.001) and the distance between the seizure foci and DBS site (|r| = 0.777, p < 0.001). Significant correlations were independent of variance in the DBS sites (|r| = 0.148, p = 0.57). CONCLUSION: These findings suggest that functional connectomic profile is a potential reliable non-invasive biomarker to predict ANT-DBS outcomes. Accordingly, the identification of ANT responders could decrease the surgical risk for patients who may not benefit and optimize the cost-effective allocation of health care resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Neurological Disorders, Beijing, China; Department of Functional Neurosurgery, Beijing Institute of Functional Neurosurgery, Xuanwu Hospital, Clinical Center for Epilepsy, Capital Medical University,…
- National Center for Neurological Disorders, Beijing, China; Department of Neurology, Xuanwu Hospital, Clinical Center for Epilepsy, Capital Medical University, Beijing, China.
- Center for Brain Circuit Therapeutics, Departments of Neurology, Psychiatry, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
- Center for Brain Circuit Therapeutics, Departments of Neurology, Psychiatry, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, United States; Department of Neurology, Charité-Universitätsmediz…
- Department of Neurology and Neurological Sciences and Neurosurgery by Courtesy, Stanford University School of Medicine, Palo Alto, CA, USA.
- National Center for Neurological Disorders, Beijing, China; Department of Neurology, Xuanwu Hospital, Clinical Center for Epilepsy, Capital Medical University, Beijing, China; Chinese Institute for Brain Research, Beiji…
Förderung
- Natural Science Foundation of Beijing Municipality
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Xu, C., Qi, L., Wang, X., Schaper, F. L. W. V. J., Wu, D., Yu, T., Yan, X., Jin, G., Wang, Q., Wang, X., Huang, X., Wang, Y., Chen, Y., Liu, J., Wang, Y., Horn, A., Fisher, R. S., & Ren, L. (2023). Functional connectomic profile correlates with effective anterior thalamic stimulation for refractory epilepsy. Brain Stimulation, 16(5), 1302-1309. https://doi.org/10.1016/j.brs.2023.08.020
Vancouver
Xu C, Qi L, Wang X, Schaper FLWVJ, Wu D, Yu T, et al. Functional connectomic profile correlates with effective anterior thalamic stimulation for refractory epilepsy. Brain Stimulation. 2023;16(5):1302-1309. doi:10.1016/j.brs.2023.08.020
BibTeX
@article{Xu2023,
author = {Xu, Cuiping and Qi, Lei and Wang, Xueyuan and Schaper, Frédéric L W V J and Wu, Di and Yu, Tao and Yan, Xiaoming and Jin, Guangyuan and Wang, Qiao and Wang, Xiaopeng and Huang, Xinqi and Wang, Yuke and Chen, Yuanhong and Liu, Jinghui and Wang, Yuping and Horn, Andreas and Fisher, Robert S and Ren, Liankun},
title = {Functional connectomic profile correlates with effective anterior thalamic stimulation for refractory epilepsy},
journal = {Brain Stimulation},
year = {2023},
volume = {16},
number = {5},
pages = {1302--1309},
doi = {10.1016/j.brs.2023.08.020}
}
EUVIMED